CP
MDT icon

Corbenic Partners’s Medtronic MDT Stock Holding History

Corbenic Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-105
Closed -$11K – 263
2021
Q4 		$11K Sell
105
-214
-67% -$24.8K ﹤0.01% 167
2021
Q3 		$40K Buy
319
+24
+8% +$3.11K 0.01% 91
2021
Q2 		$37K Buy
295
+214
+264% +$26.9K 0.01% 96
2021
Q1 		$10K Buy
+81
New +$9.49K ﹤0.01% 174
2017
Q2 		– Sell
-119
Closed -$10K – 187
2017
Q1 		$10K Hold
119
– – 0.01% 136
2016
Q4 		$8K Buy
+119
New +$9.35K 0.01% 140

Other funds holding MDT

WA
WestEnd Advisors Charlotte, North Carolina $4.14B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Corbenic Partners's MDT Position: Q1 2022 in Review

Corbenic Partners sold out of Medtronic (MDT) in Q1 2022, closing a stake of 105 shares — an estimated $11K sold.

Corbenic Partners first reported a position in MDT in Q4 2016 and held it in 6 quarters. The position peaked at $40K in Q3 2021. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • Corbenic Partners reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
  • Corbenic Partners sold 105 Medtronic shares in Q1 2022, an estimated $11K.
  • Corbenic Partners first reported a position in Medtronic in Q4 2016 and held it in 6 quarters.
  • Corbenic Partners's Medtronic position peaked at $40K in Q3 2021.
  • 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Corbenic Partners's 13F filing for Q1 2022, filed 14 Apr 2022.